The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective
eyedrop, in the treatment of acute infectious conjunctivitis.